Conditions: Type 2 Diabetes Mellitus
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 357
Healthy volunteers: no

Brief summary:
The current study investigates Welchol as monotherapy to improve glycemic control in subjects with Type 2 Diabetes Mellitus not adequately controlled with diet and exercise alone. The study will evaluate if Welchol monotherapy for Type 2 Diabetes Mellitus will be safe, well tolerated and efficacious.

Detailed description:

Arms:
arm 1: Welchol 625mg tablets arm 2: placebo

Interventions: intervention 1: Welchol intervention 2: Placebo
Intervention descriptions: intervention 1: Welchol 625mg tablets intervention 2: placebo

Protocol document: